Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The Food and Drug Administration was set to release new guidance on COVID booster shots ahead of the fall season, but that's ...

The FDA may be making changes to how it handles COVID-19 booster shots. The agency’s top official says they’re taking a ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

Louisiana Surgeon General Ralph Abraham backs bill to deregulate the drug ivermectin and recommends it to his own patients.

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...

Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...